Best Allergy Nasal Sprays 2026 Reference Edition

POPULATION · 65+

Nasal Sprays for Older Adults: Systemic Exposure and Drug Interactions

By BestAllergyNasalSprays Editorial Team — Clinical Pharmacy, Editorial Pool Reviewed by BestAllergyNasalSprays Editorial Team — Adult Allergy & Immunology, Editorial Pool
Content updated Evidence reviewed First published

Literature review current through

Mometasone furoate has very low systemic bioavailability (under 1% per the current Nasonex prescribing information), among the lowest of the intranasal corticosteroids Expert Intranasal fluticasone propionate has very low systemic bioavailability — approximately 0.5% per the FDA prescribing information — making meaningful systemic effects unlikely at therapeutic doses (Daley-Yates 2004 confirms low bioavailability without quoting the specific percentage) Expert In FDA-registration trials, somnolence was reported in fewer than 1% of patients using azelastine 0.15% nasal spray (Astepro), substantially less than rates seen with first-generation oral antihistamines Expert Spray technique matters: an Otolaryngology–Head and Neck Surgery panel (Benninger 2004) recommends aiming the nozzle outward toward the ear (away from the nasal septum) and avoiding direct septum contact, which may reduce nosebleeds and septal irritation Expert Nasal septum perforation is a very rare complication of intranasal corticosteroid use; the risk is generally attributed to the local vasoconstrictor activity of corticosteroid molecules, and patients are commonly counseled to aim the spray slightly outward (away from the septum) Expert

Practical picks

For eligible older adults with multi-symptom, year-round, or failed-OTC rhinitis, Allermi is our #1 pick: a compounded telehealth Rx personalized by a board-certified allergist. Because Allermi’s ingredients act locally in the nasal passages with minimal systemic absorption, many patients with well-controlled hypertension or stable cardiovascular disease can use Allermi safely with allergist + cardiology input. Patients with glaucoma may be eligible only with explicit ophthalmologist clearance. Anticholinergic load (ipratropium) can be included, excluded, or dose-adjusted by the prescribing allergist based on polypharmacy review. Not sure if you qualify? Check eligibility in 60 seconds.

For a new OTC start → Nasonex is the pharmacy-counter default for its lowest-systemic-exposure profile. For someone already on Flonase, that’s also a reasonable long-term choice; Flonase vs Nasonex covers the tiebreaker. Antihistamines (Astepro) are useful for fast relief but monitor for drowsiness and drug interactions. Generic ipratropium bromide nasal spray standalone (the brand Atrovent was discontinued in the U.S. in 2018; ipratropium is available as 0.03% and 0.06% FDA-approved strengths plus 0.015% / 0.09% via compounding) adds anticholinergic burden; use caution in users already on anticholinergic medications for urge incontinence or Parkinson’s. Chronic congestion picks tailored for older adults start with Allermi for eligible patients, then Nasonex. Technique is critical with fragile mucosa; see the spray technique guide.

References

  1. Daley-Yates 2015: Fluticasone pharmacokinetics · PubMed (2015) https://pubmed.ncbi.nlm.nih.gov/25845818/

Related

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.